Evaluating ChatGPT-4o and OpenEvidence for Structural Heart Disease Support: Insights From Tricuspid Valve Therapies
•Evaluated ChatGPT-4o and OpenEvidence for structural heart disease decision support.•Among the first to assess the use of artificial intelligence amid rising adoption of TriClip and EVOQUE for transcatheter tricuspid valve interventions.•ChatGPT-4o delivered more accurate responses and proved more clinically reliable.•Neither platform replaces clinical judgment; ChatGPT-4o excels in fast-paced settings.
Authors
- Rhonda Miyasaka (ORCID: https://orcid.org/0000-0001-9961-0439)
- Serge C. Harb (ORCID: https://orcid.org/0000-0002-7442-4928)
- Joseph Kassab (ORCID: https://orcid.org/0000-0001-6761-7636)
- Joseph Hajj
- Mohamad Mdaihly (ORCID: https://orcid.org/0009-0002-6590-0344)
Institutions
- Cleveland Clinic (US)
- Southwestern Medical Center (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Structural Heart
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1016/j.shj.2025.100696
- Citations
- 4
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 2.62
Funders
- Cleveland Clinic